Welcome to AnavexTM Life Sciences Corp.
Anavex Life Sciences Corp. is a publicly traded biopharmaceutical company dedicated to the development of differentiated therapeutics for the treatment of neurodegenerative diseases including Alzheimer’s disease, other central nervous system (CNS) diseases, pain and various types of cancer.
Anavex corporate presentation at 18th Annual BIO CEO & Investor Conference on February 9, 2016
Anavex rings the Nasdaq Stock Market Closing Bell on Oct. 30, 2015
Reverse stock split associated with uplisting to Nasdaq Capital Market.